198 related articles for article (PubMed ID: 2039993)
1. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B
Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993
[TBL] [Abstract][Full Text] [Related]
2. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
3. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Takahashi H; Simizu B
Cancer Res; 1993 Jul; 53(13):3179-85. PubMed ID: 8319227
[TBL] [Abstract][Full Text] [Related]
4. myc gene amplification and expression in primary human neuroblastoma.
Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
[TBL] [Abstract][Full Text] [Related]
6. N-myc amplification and cell proliferation rate in human neuroblastoma.
Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
[TBL] [Abstract][Full Text] [Related]
7. Prognostic prediction in neuroblastomas: clinical significance of combined analysis for Ha-ras p21 expression and N-myc gene amplification.
Tanaka T; Seeger RC; Tanabe M; Hiyama E; Shimoda H; Ida N
Cancer Detect Prev; 1994; 18(4):283-9. PubMed ID: 7982238
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening.
Matsunaga T; Shirasawa H; Hishiki T; Yoshida H; Kouchi K; Ohtsuka Y; Kawamura K; Etoh T; Ohnuma N
Clin Cancer Res; 2000 Aug; 6(8):3199-204. PubMed ID: 10955804
[TBL] [Abstract][Full Text] [Related]
9. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma: inverse relationship between expression of N-myc and NGF-r.
Christiansen H; Christiansen NM; Wagner F; Altmannsberger M; Lampert F
Oncogene; 1990 Mar; 5(3):437-40. PubMed ID: 2156211
[TBL] [Abstract][Full Text] [Related]
12. Genomic and metabolic aspects of neuroblastomas in children under one year of age.
Nakagawara A; Zaizen Y; Suita S
Prog Clin Biol Res; 1991; 366():115-25. PubMed ID: 2068132
[No Abstract] [Full Text] [Related]
13. Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome.
Grady-Leopardi EF; Schwab M; Ablin AR; Rosenau W
Cancer Res; 1986 Jun; 46(6):3196-9. PubMed ID: 2421891
[TBL] [Abstract][Full Text] [Related]
14. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
15. [Oncogene amplification in human neuroblastomas].
Kanda N; Tsuchida Y; Hayashi Y; Ise T; Takayama J; Utakoji T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):661-6. PubMed ID: 3963837
[TBL] [Abstract][Full Text] [Related]
16. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
17. Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR.
Sartelet H; Grossi L; Pasquier D; Combaret V; Bouvier R; Ranchère D; Plantaz D; Munzer M; Philip T; Birembaut P; Zahm JM; Bergeron C; Gaillard D; Pasquier B
J Pathol; 2002 Sep; 198(1):83-91. PubMed ID: 12210067
[TBL] [Abstract][Full Text] [Related]
18. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM
Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
20. Detection of N-myc gene amplification in bone marrow specimen of stage IV neuroblastoma patients.
Brack T; Scholz RB; Milde-Langosch K; Heinsohn S; Löning T; Kabisch H
Cancer Detect Prev; 1992; 16(3):185-92. PubMed ID: 1458508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
